NextCure, Inc.
General ticker "NXTC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $17.8M (TTM average)
NextCure, Inc. follows the US Stock Market performance with the rate: 17.5%.
Estimated limits based on current volatility of 7.9%: low 11.74$, high 13.76$
Factors to consider:
- Total employees count: 43 (-15.7%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Clinical trial success, Manufacturing risks, Reimbursement risks, Cybersecurity threats
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.14$, 18.94$]
- 2025-12-31 to 2026-12-31 estimated range: [3.96$, 12.61$]
Financial Metrics affecting the NXTC estimates:
- Negative: with PPE of -5.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -166.92 <= 0.33
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of 226.24 > -0.66
- Positive: Shareholder equity ratio, % of 80.97 > 63.39
- Negative: negative Industry operating cash flow (median)
Short-term NXTC quotes
Long-term NXTC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $75.91MM | $67.64MM | $59.75MM |
| Operating Income | $-75.91MM | $-67.64MM | $-59.75MM |
| Non-Operating Income | $1.18MM | $4.91MM | $4.09MM |
| R&D Expense | $54.20MM | $47.93MM | $41.49MM |
| Income(Loss) | $-74.73MM | $-62.72MM | $-55.65MM |
| Profit(Loss)* | $-74.73MM | $-62.72MM | $-55.65MM |
| Stockholders Equity | $167.53MM | $114.42MM | $65.47MM |
| Inventory | $0.70MM | $0.00MM | $0.00MM |
| Assets | $184.16MM | $128.04MM | $80.86MM |
| Operating Cash Flow | $-53.89MM | $-52.97MM | $-40.80MM |
| Capital expenditure | $2.12MM | $0.82MM | $0.47MM |
| Investing Cash Flow | $67.98MM | $39.27MM | $55.31MM |
| Financing Cash Flow | $0.20MM | $0.15MM | $0.14MM |
| Earnings Per Share** | $-32.32 | $-27.04 | $-23.88 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.